Anaplastic Thyroid Cancer: A report of 5 consecutive cases treated successfully with nab-Paclitaxel.

被引：0
|
作者：
Dean, Andrew Peter
Goh, Robin Yeong Hong
Smith, Peter
机构：
[1] St John God Hosp Subiaco, Subiaco, WA, Australia
[2] Western Gen Surg, Subiaco, WA, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17095
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17095
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anaplastic thyroid cancer: A report of six consecutive cases treated successfully with nab-paclitaxel.
    Travers, Nicholas
    Cronin, Eleanor
    Marinova, Mira
    Smith, Peter
    Dean, Andrew Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] CASE STUDY: RESPONSE OF ANAPLASTIC THYROID CANCER TO NAB-PACLITAXEL
    McMullen, M.
    Dean, A.
    Hoon, T. J.
    Ong, J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 60 - 60
  • [3] Radiotherapy combined with immunotherapy successfully treated one case of anaplastic thyroid cancer: A case report
    Xing, Yurou
    Wang, Yongsheng
    Wu, Xin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Outcomes of patients with borderline-resectable pancreatic cancer treated with FOLFIRINOX versus gemcitabine plus nab-paclitaxel.
    Templeton, Shaina D'Lee
    Moser, Michael
    Chalchal, Haji I.
    Shaw, John
    Luo, Yigang
    Zaidi, Adnan
    Ahmed, Shahid
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [5] THREE CASES OF HEMODIALYSIS PATIENTS WITH ADVANCED GASTRIC CANCER TREATED WITH PACLITAXEL AND NAB PACLITAXEL
    Kashiwada, Tomomi
    Aragane, Naoko
    Kimura, Shinya
    ANNALS OF ONCOLOGY, 2014, 25
  • [6] Sarcopenia predicts dose-limiting toxicity in metastatic pancreatic cancer treated with gemcitabine plus nab-paclitaxel.
    Youn, Susie
    Chen, Angela
    Ha, Vincent
    Chambers, Carole
    Eurich, Dean T.
    McCall, Michael
    Sawyer, Michael B.
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Chemotherapy-induced neutropenia as a prognostic factor in patients with unresectable pancreatic cancer treated with gemcitabine and nab-paclitaxel.
    Kan, Motoyasu
    Imaoka, Hiroshi
    Ikeda, Masafumi
    Mitsunaga, Shuichi
    Ohno, Izumi
    Hashimoto, Yusuke
    Sasaki, Mitsuhito
    Takahashi, Hideaki
    Watanabe, Kazuo
    Umemoto, Kumiko
    Kimura, Gen
    Shibuki, Taro
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [8] MYXEDEMA COMA - REPORT ON 5 SUCCESSFULLY TREATED CASES
    KHALEELI, AA
    POSTGRADUATE MEDICAL JOURNAL, 1978, 54 (638) : 825 - 829
  • [9] The role of nab™-paclitaxel in managing metastatic breast cancer: a report of three cases
    Davidson, Neville
    EJC SUPPLEMENTS, 2010, 8 (01): : 11 - 18
  • [10] PAZOPANIB AND PACLITAXEL SYNERGIZE IN ANAPLASTIC THYROID CANCER
    不详
    CANCER DISCOVERY, 2013, 3 (02) : 133 - 133
12345